KR20110120802A - A novel b. subtilis sp. strain and fermented soymilk for anti-gastric cancer by using the same - Google Patents
A novel b. subtilis sp. strain and fermented soymilk for anti-gastric cancer by using the same Download PDFInfo
- Publication number
- KR20110120802A KR20110120802A KR1020100061766A KR20100061766A KR20110120802A KR 20110120802 A KR20110120802 A KR 20110120802A KR 1020100061766 A KR1020100061766 A KR 1020100061766A KR 20100061766 A KR20100061766 A KR 20100061766A KR 20110120802 A KR20110120802 A KR 20110120802A
- Authority
- KR
- South Korea
- Prior art keywords
- soymilk
- fermented
- strain
- subtilis
- gastric cancer
- Prior art date
Links
- 235000013322 soy milk Nutrition 0.000 title claims abstract description 60
- 235000014469 Bacillus subtilis Nutrition 0.000 title claims abstract description 21
- 208000005718 Stomach Neoplasms Diseases 0.000 title claims abstract description 11
- 206010017758 gastric cancer Diseases 0.000 title claims abstract description 11
- 201000011549 stomach cancer Diseases 0.000 title claims abstract description 11
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 8
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 7
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 230000001629 suppression Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 235000010469 Glycine max Nutrition 0.000 abstract description 13
- 244000068988 Glycine max Species 0.000 abstract description 13
- 239000000203 mixture Substances 0.000 abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 2
- 239000008103 glucose Substances 0.000 abstract description 2
- 238000010438 heat treatment Methods 0.000 abstract description 2
- 244000063299 Bacillus subtilis Species 0.000 abstract 3
- 238000001816 cooling Methods 0.000 abstract 1
- 238000000855 fermentation Methods 0.000 description 24
- 230000004151 fermentation Effects 0.000 description 24
- 241000894006 Bacteria Species 0.000 description 12
- 230000001965 increasing effect Effects 0.000 description 12
- 230000002000 scavenging effect Effects 0.000 description 11
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 239000000523 sample Substances 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 8
- 201000011510 cancer Diseases 0.000 description 8
- 235000013336 milk Nutrition 0.000 description 8
- 239000008267 milk Substances 0.000 description 8
- 210000004080 milk Anatomy 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 6
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical group [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 5
- XKMRRTOUMJRJIA-UHFFFAOYSA-N ammonia nh3 Chemical compound N.N XKMRRTOUMJRJIA-UHFFFAOYSA-N 0.000 description 5
- 230000010261 cell growth Effects 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 241000193755 Bacillus cereus Species 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 235000013618 yogurt Nutrition 0.000 description 4
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 3
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 229940079877 pyrogallol Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 2
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 2
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 241000831652 Salinivibrio sharmensis Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000015140 cultured milk Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000021107 fermented food Nutrition 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 229960004279 formaldehyde Drugs 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000000401 methanolic extract Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 101150079601 recA gene Proteins 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000301512 Bacillus cereus ATCC 14579 Species 0.000 description 1
- 101000856500 Bacillus subtilis subsp. natto Glutathione hydrolase proenzyme Proteins 0.000 description 1
- 241000003114 Bacillus velezensis FZB42 Species 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- -1 Hydroxy radicals Chemical class 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 101710162629 Trypsin inhibitor Proteins 0.000 description 1
- 229940122618 Trypsin inhibitor Drugs 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 208000009956 adenocarcinoma Diseases 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000014048 cultured milk product Nutrition 0.000 description 1
- 238000006481 deamination reaction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000019256 formaldehyde Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000002338 glycosides Chemical group 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000009422 growth inhibiting effect Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- RSAZYXZUJROYKR-UHFFFAOYSA-N indophenol Chemical compound C1=CC(O)=CC=C1N=C1C=CC(=O)C=C1 RSAZYXZUJROYKR-UHFFFAOYSA-N 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- KNMNNEPMKDJBDW-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-1-(2,6-dimethylphenoxy)propan-2-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCNC(C)COC1=C(C)C=CC=C1C KNMNNEPMKDJBDW-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 239000001967 plate count agar Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 230000007065 protein hydrolysis Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/60—Drinks from legumes, e.g. lupine drinks
- A23L11/65—Soy drinks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C11/00—Milk substitutes, e.g. coffee whitener compositions
- A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
- A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
- A23C11/103—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
- A23C11/106—Addition of, or treatment with, microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/50—Fermented pulses or legumes; Fermentation of pulses or legumes based on the addition of microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/302—Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
- C12R2001/125—Bacillus subtilis ; Hay bacillus; Grass bacillus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Agronomy & Crop Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Beans For Foods Or Fodder (AREA)
Abstract
Description
본 발명은 신규한 B. Subtilis sp . 균주 및 그의 인체 위암억제 용도에 관한 것이다.
The present invention is a novel B. Subtilis sp . It relates to a strain and its use for suppressing human gastric cancer.
두유의 주원료인 콩은 isoflavone, saponin, phytic acid, trypsin inhibitor, oligosaccharides 등의 기능성 성분이 많이 함유되어 있고 양질의 단백질과 지방질이 풍부해 혈압 조절 작용, 혈전 용해능, 항돌연변이 및 항암작용, 면역증강 효과, 혈중 콜레스테롤 저하능 등의 다양한 생리활성을 가진다고 알려져 있다. 콩은 발효를 거치면서 균주가 생성하는 효소의 작용으로 콩 단백질이 분해되어 새롭게 생성된 물질인 isoflavone의 aglycone, 유리아미노산, 펩타이드 등을 함유하게 된다. 두유, 두부 같은 비발효 식품은 aglycone의 비율이 10% 미만에 불과하지만 청국장, 된장 같은 발효식품은 약 70-80% 정도로 증가한다. Aglycone형태는 배당체 형태보다 생리활성도 높고 흡수가 빨라서 발효대두식품은 비발효 대두식품보다 여러 생리활성이 강하여 질병예방에 더 효과적이다.Soybean, the main ingredient of soy milk, is rich in functional ingredients such as isoflavone, saponin, phytic acid, trypsin inhibitor, oligosaccharides, and it is rich in high quality protein and fat. It is known to have various physiological activities such as effects, blood cholesterol lowering ability. Soybeans are fermented by enzymes produced by strains to break down soy protein, which contains aglycone, free amino acids, and peptides of isoflavone. Non-fermented foods such as soy milk and tofu have less than 10% of aglycone, but fermented foods such as Cheonggukjang and Doenjang increase by about 70-80%. Aglycone form has higher physiological activity and faster absorption than glycoside form, so fermented soybean food is more effective in disease prevention because it has many physiological activities than non-fermented soybean food.
두유는 대두를 갈아 만든 음료의 형태로 수용성 단백질과 불포화지방산 및 필수 아미노산의 함량이 높아 영양학적으로 우수하지만 특유의 콩 비린내로 인해 이용성이 저하되는 문제점이 있었다. 발효두유는 발효를 통해 새로운 풍미를 부여하거나 불쾌취를 제거할 수 있고 소화율도 높일 수 있는 장점이 있다. 시중에 판매중인 발효두유는 Lactobacillus acidophilus , Lab . bulgaricus 등 유산균을 이용하여 제조한 제품과 사례는 많으나, 두유의 원재료인 콩에서 유래한 Bacillus 속 균주를 이용하여 유음료에 적용시킨 사례는 거의 없었다. 청국장에서 분리된 B. subtilis는 혈전분해효소를 생산하고 생리활성 물질인 poly-γ-glutamic acid (PGA) 점질물을 생산하는 우수한 균주로 보고되고 있으며, 장내 부패균이 생성하는 indole, 발암물질 등의 물질을 감소시키고 흡착시켜 배설시키는 작용을 한다.
Soy milk has a problem in that the soy milk is in the form of a drink made by grinding soybeans, which is nutritionally superior due to high content of water-soluble protein, unsaturated fatty acids, and essential amino acids, but its availability is lowered due to its unique soy fishy smell. Fermented soy milk has the advantage that it can give a new flavor or remove odor through fermentation and increase digestibility. Fermented soy milk on the market is Lactobacillus acidophilus , Lab . There are many products and cases manufactured using lactic acid bacteria such as bulgaricus , but Bacillus derived from soy milk, a raw material of soy milk. Few strains have been applied to milk beverages using the genus strains. B. subtilis isolated from Cheonggukjang has been reported as an excellent strain that produces thrombolytic enzymes and produces bioactive substance, poly-γ-glutamic acid (PGA), and is known as indole and carcinogens produced by intestinal rot. To reduce and adsorb and excrete.
본 발명자들은 B. Subtilis KC-1 균주(KCCM에 등록된 번호는 42923호)로 확인했던 전남 순창지역의 청국장에서 분리한 규주를 동정하고 이 균주를 이용하여 발효두유를 제조하고자 시도하였다. 통상의 청국장은 발효정도에 따라 이화학적 성분 및 γ-GTP 활성이 향상되는데, 본 발명 청국장 유래균으로 발효한 발효두유에서도 발효정도에 따라 성분 및 기능성이 변화하는지 확인하는 데 그 목적이 있다. 따라서, 본 발명에서는 B. 속 균주의 발효두유의 이화학적 변화를 살펴보고, 나아가 항산화능 및 발효정도에 따른 (pH 감소) 발효두유의 성분변화, 기능성 차이를 확인하는데 다른 목적이 있다.
We believe that B. Subtilis Kyuju isolated from Cheonggukjang in Sunchang, Jeonnam, Korea, identified as KC-1 strain (KCCM No. 42923), and attempted to produce fermented soymilk using this strain. The conventional Cheonggukjang improves the physicochemical component and γ-GTP activity according to the fermentation degree. The purpose of the present invention is to determine whether the ingredients and functionality of the fermented soymilk fermented with the present invention Cheonggukjang-derived bacteria change according to the fermentation degree. Therefore, the present invention is to examine the physicochemical changes of fermented soymilk of the strain B. genus, and further to determine the component changes and functional differences of fermented soymilk according to the antioxidant capacity and the degree of fermentation (pH reduction).
본 발명의 상기 목적은 Bacillus 속 신규한 균주를 동정하고, 이를 순수배양하여 발효두유를 제조하고 그 항암기능성을 확인하므로써 달성하였다.
The object of the present invention Bacillus By identifying new strains of the genus, pure cultured it was achieved by producing fermented soymilk and confirming its anticancer function.
본 발명 B. Subtilis KC -1 균주는 DDPH, 히드록시기 소거활성 SOD 활성이 우수하여 항산화효과가 뛰어나고 AGS 인체위암세포 성장 저해효과가 뛰어나 본 균주를 이용한 발효두유는 위암예방 기능성 식품조성물로 이용할 수 있는 뛰어난 효과가 있다.
Inventive B. Subtilis KC- 1 strain has excellent DDPH, hydroxy scavenging activity SOD activity, excellent antioxidant effect and AGS human gastric cancer cell growth inhibitory effect, fermented soy milk using this strain can be used as a functional food composition for gastric cancer prevention.
도1은 본 발명 균주에 의한 발효두유중 세포수의 변화(A)와 산도 및 점도 변화(B)를 보인 그래프이다.
도2는 본 발명 균주에 의한 발효두유의 DPPH 기 소거능(A)과 OH 기 소거능(B)을 보인 그래프이다.
도3은 본 발명 균주에 의한 발효두유의 SOD 유사 활성을 보인 그래프이다.
도4는 본 발명 균주에 의한 발효두유의 AGS 인체 위암 세포의 성장억제효과를 보인 그래프이다.1 is a graph showing the change in cell number (A) and acidity and viscosity (B) of fermented soymilk by the strain of the present invention.
Figure 2 is a graph showing DPPH group scavenging ability (A) and OH group scavenging ability (B) of fermented soy milk by the strain of the present invention.
Figure 3 is a graph showing the SOD-like activity of fermented soy milk by the strain of the present invention.
Figure 4 is a graph showing the growth inhibitory effect of AGS human gastric cancer cells of fermented soy milk by the strain of the present invention.
실시예Example 1. 청국장 시료의 제조 1. Preparation of Cheonggukjang Sample
본 실시예에서는 전북 순창 고추장민속마을에서 전통적인 방법으로 생산되어 시판되고 있는 대표적인 청국장 제품 6종 (K-, M-, Mn-, O-, Os-, H-청국장)을 구입하여 이화학실험 및 관능평가를 실시한 후 선택된 K-, M-, H-청국장을 실험에 이용하였다. 청국장 시료는 동결건조한 후 마쇄하여 시료에 20배 (v/v)의 메탄올을 첨가하였다. 12시간 교반을 3회 반복하고 여과한 후 회전식 진공농축기 (EYELA, Tokyo Rikakikai Co., Japan)로 농축하여 메탄올추출물을 얻었다. 이들 추출물을 DMSO(dimethyl sulfoxide)에 희석하여 실험에 사용하였다.
In this example, 6 kinds of representative Cheonggukjang products (K-, M-, Mn-, O-, Os-, H-Cheongkukjang) produced and marketed in the traditional method in Sunchang Gochujang Folk Village, Jeonbuk, Korea were purchased and tested for physical and chemical performance. After the evaluation, selected K-, M- and H-Cheongkukjang were used for the experiment. Cheonggukjang samples were lyophilized and crushed to add 20 times (v / v) methanol to the samples. The mixture was stirred three times for 12 hours, filtered and concentrated using a rotary vacuum concentrator (EYELA, Tokyo Rikakikai Co., Japan) to obtain a methanol extract. These extracts were diluted in dimethyl sulfoxide (DMSO) and used for the experiment.
실시예Example 2. 2. BacillusBacillus 균의 분리 및 동정Isolation and Identification of Bacteria
본 실시예에서는 멸균한 증류수에 10배 희석된 청국장 시료를 백금이로 취하여 nutrient agar plate (beef extract 3 g/L, peptone 5 g/L, agar 15 g/L)에 획선평판법으로 도말하고 37℃에서 24시간 배양하였다. 생성된 콜로니 중에서 모양이 크고 선명한 것을 선별한 뒤, 다시 nutrient broth에 접종한 후 2차 배양하였다. 최종적으로 K-청국장 (순창 고추장민속마을 김용순 전통식품)에서 단일 균주 3종을 분리하였고, 이를 각각 KC-1, KC-2, KC-3로 명명하였다. 이들을 동정하기 위해 recA gene을 PCR로 증폭하여 각각의 서열을 얻었고(서열번호 1-3), 이 서열을 BLAST 상동성 검색(homology search)을 통하여 다른 균주와의 염기서열 상동성을 비교한 뒤 최종 동정하였다.In this example, a sample of Cheonggukjang diluted 10-fold in sterile distilled water was taken as platinum, and plated on a nutrient agar plate (beef extract 3 g / L, peptone 5 g / L, agar 15 g / L) by a flat plate method and 37 ° C. Incubated for 24 hours. The colonies were selected from the resulting colonies with clear shapes and then inoculated in nutrient broth, followed by secondary culture. Finally, three single strains were isolated from K-Cheonggukjang (Kim Yong-soon traditional food in Soonchang Gochujang Folk Village) and named KC-1, KC-2, and KC-3, respectively. In order to identify them, each sequence was obtained by amplifying the recA gene by PCR (SEQ ID NOs: 1-3), and comparing the sequence homology with other strains through BLAST homology search. I identified it.
그 결과, KC-1은 B. subtilis recA gene과 98%의 일치성을 나타내어 최종적으로 B. subtilis로 동정되었다. KC-2는 B. amyloliquefaciens FZB42 균과 99%의 염기서열 상동성을 보여 B. amyloliquefaciens로 동정되었으며, KC -3은 B. cereus ATCC 14579 균과 99%의 상동성을 보여 B. cereus 로 최종 동정되었다. 이들 중 본 발명 공시재료인 B. Subtilis KC -1 균주를 2009년 3월 26일자로 한국미생물보존센터에 KCCM 42923호로 기탁하였다.As a result, KC-1 is B. subtilis 98% concordance with the recA gene was finally identified as B. subtilis . KC-2 is B. amyloliquefaciens FZB42 illustrates a base sequence homology of bacteria and 99% were identified as B. amyloliquefaciens, B. cereus ATCC 14579 KC -3 is shown a homology of bacteria and 99% of the final identified as B. cereus It became . Among them , B. Subtilis , the present disclosure material The KC- 1 strain was deposited as KCCM 42923 with the Korea Microorganism Conservation Center on March 26, 2009 .
따라서, K-청국장에서 분리된 대표적인 균 3종은 B. subtilis, B. amyloliquefaciens, B. cereus이며, 이 균들은 모두 107~108/g 정도로 존재했으므로 K-청국장의 발효에 중심이 되는 미생물일 것으로 생각된다. Therefore, three representative bacteria isolated from K-Cheonggukjang are B. subtilis , B. amyloliquefaciens, and B. cereus , and these bacteria were all present in the range of 10 7 ~ 10 8 / g, which are the microorganisms that are central to fermentation of K-Cheonggukjang. It is thought to be.
실시예Example 3. 3. 발효두유Fermented Soymilk 및 추출물 제조 And extract manufacturer
실험에 사용된 두유는 (주)동화식품 (경남 양산시)에서 구입한 것으로 첨가물이 들어있지 않은 미국산 콩으로 만든 순대두유이다. 구입한 두유는 고압멸균기로 121℃, 15분간 가열처리하여 멸균한 후 30℃로 냉각하여 실험에 사용하였다. 두유에 접종한 B. subtilis KC-1 KCCM 42923는 전통 청국장에서 분리 동정된 균으로, nutrient broth 배지에서 37℃, 24시간 배양하였다. 멸균된 두유에는 발효에 이용될 glucose를 두유 양의 1% (w/w) 첨가하고 약 107/g으로 배양된 균을 1%(v/w) 접종하여 37℃, 100 rpm, shaking water bath에서 발효하였다.Soy milk used in the experiment was purchased from Donghwa Food Co., Ltd. (Yangsan, Gyeongnam) and is a soybean soybean milk made from US soybeans containing no additives. The soy milk purchased was sterilized by heating at 121 ° C. for 15 minutes using an autoclave and then cooled to 30 ° C. for use in experiments. B. subtilis inoculated with soymilk KC-1 KCCM 42923 was isolated from traditional Cheonggukjang and incubated for 24 hours at 37 ℃ in nutrient broth medium. Sterilized soymilk was added with 1% (w / w) of glucose for fermentation and 1% (v / w) of the incubated bacteria at about 107 / g. Fermented.
발효가 끝난 두유는 동결건조 시킨 후 이를 마쇄하여 시료의 20배 (w/v)의 methanol을 첨가하고 24시간 교반을 3회 반복한 후 여과하였다. 여과물을 회전식 진공농축기 (EYELA, Tokyo Rikakikai Co., Japan)로 농축해 추출물을 얻고 dimethyl sulfoxide (DMSO)에 희석하여 사용하였다.
After fermentation, the soy milk was lyophilized, and then ground. Then, 20 times (w / v) methanol was added to the sample, and the mixture was filtered three times for 24 hours and then filtered. The filtrate was concentrated with a rotary vacuum concentrator (EYELA, Tokyo Rikakikai Co., Japan) to obtain an extract and diluted with dimethyl sulfoxide (DMSO).
실험예Experimental Example 1. 일반 특성 측정 1. Measure general characteristics
균 (B. Subtilis)수 측정 : 발효가 완료된 직후 1 mL의 시료를 무균적으로 취하여 10 배수로 희석하여 plate count agar (Difco Co., Detroit, USA) 배지에 접종하고 37℃에서 48시간 배양한 후 집락수를 계수하였다.
B. Subtilis : Determination of the number of B. Subtilis : Immediately after fermentation is completed, 1 mL of sample is aseptically taken and diluted to 10-fold, inoculated in plate count agar (Difco Co., Detroit, USA) medium and incubated at 37 ° C for 48 hours. Colony counts were counted.
실험예Experimental Example 2. 2. pHpH 및 산도 측정 And acidity measurements
발효두유의 pH는 pH meter (TP-93, Toko Chemical Laboratories, tokyo, Japan)를 이용하여 측정하였다. 산도는 두유 1 mL을 취하여 증류수 19 mL에 희석하여 0.1 N NaOH로 pH 8.4가 될 때까지 적정한 후 소비된 NaOH의 mL수를 %로 환산하였다.
The pH of fermented soymilk was measured using a pH meter (TP-93, Toko Chemical Laboratories, tokyo, Japan). The acidity was taken in 1 mL of soymilk, diluted in 19 mL of distilled water, titrated with 0.1 N NaOH until pH 8.4, and the mL number of NaOH consumed was converted into%.
발효두유의 pH변화에 따른 균수 및 산도를 살펴본 결과(도1A), 발효를 위해 첨가한 8.5×104 cfu/mL의 B. Subtilis sp . 균주는 pH 5.5 에서 3.4×106 cfu/㎖, pH 5.25에서 7.2×106 cfu/mL, pH 5.0에서 7.5×107 cfu/mL로 나타났다. 즉, 두유에 접종한 본 발명 B. Subtilis sp . 균주는 pH 저하와 발효시간 증가에 따라 그 균수가 증가함을 알 수 있었다. 산도의 경우 발효가 진행됨에 따라 발효 전 0.1%에서 발효 후 pH 5.0에서 0.5%로 높아졌으나, 대표적인 발효유인 요구르트에 비해서는 산생성이 미흡함을 알 수 있다. 이는 제조된 발효두유내의 lactic acid와 citric acid의 함량이 우유로 발효된 제품에 비해 현저히 낮은 것에 기인한 것으로 판단된다. 일반적으로 유산균으로 발효한 발효유의 경우 pH 4.0~4.2를 나타내고 산도는 1.0~1.1% 일 때 가장 양호한 품질을 나타낸다고 하여 본 B. Subtilis sp . 균주에 의한 발효두유 제품화시 유산균과 혼합배양하여 pH를 더 낮추고 산도를 더 높이는 것이 더 적합하다고 판단된다.
As a result of examining the number of bacteria and acidity according to pH change of fermented soy milk (Fig. 1A), 8.5 × 104 cfu / mL of B. Subtilis added for fermentation sp . The strains were 3.4 × 10 6 cfu / mL at pH 5.5, 7.2 × 10 6 cfu / mL at pH 5.25, and 7.5 × 10 7 cfu / mL at pH 5.0. That is, the present invention B. Subtilis inoculated in soymilk sp . It was found that the number of strains increased with decreasing pH and increasing fermentation time. In the case of acidity, as the fermentation progressed, the pH increased from 0.1% before fermentation to 0.5% at pH 5.0, but the acidity was insufficient compared to yogurt, which is a representative fermented milk. This is due to the fact that the content of lactic acid and citric acid in the fermented soybean milk is significantly lower than that of the milk fermented product. In general, for the fermented milk fermented with lactic acid bacteria indicates a pH 4.0 ~ 4.2 pH from 1.0 to 1.1% the most preferred quality represents the present time by B. Subtilis sp . By strain When fermented soy milk is commercialized, it is more suitable to mix with lactic acid bacteria to lower pH and increase acidity.
실험예Experimental Example 3. 점도 측정 3. Viscosity Measurement
점도는 Brookfield 점도계 (Viscometer, Model DV-I, Brookfield Engineering Lab. Inc., Stoughton, MA, USA)를 사용하여 실온에서 spindle No.3로 100rpm, 60초간 회전시킨 후 측정하였다.
Viscosity was measured after rotating at 100 rpm for 60 seconds with spindle No. 3 at room temperature using a Brookfield viscometer (Viscometer, Model DV-I, Brookfield Engineering Lab. Inc., Stoughton, MA, USA).
일반적으로 요구르트 같은 발효유제품은 소비자의 기호도가 점도에 의해 크게 좌우되므로 발효과정 중의 점도를 측정해 본 결과, 두유의 점도는 127 cps이었으나 발효두유는 발효과정에 따라 pH 5.5, 5.25, 5.0에서 각각 325 cps, 621 cps, 712 cps로 측정되었다(도1B). 점도는 pH 5.5와 pH 5.25사이에 점도가 크게 증가해 약간의 curd가 생성되고 적정산도의 변화와 같은 경향을 나타내었고 관능평가에서도 발효가 될수록 새콤한 맛이 증가되는 경향을 보였다. Rasic과 Kurmann은 요구르트의 점도는 요구르트 혼합액의 총 고형분 함량과 사용균주의 단백질 가수분해 정도, slime 생성능력과 산생성력에 영향을 받는다고 보고하였다. 유산균으로 발효한 우유의 점도는 다량의 유기산 생성 및 casein과 유청단백질의 응집으로 인해 높은 점도 (130 cps~1930 cps)를 나타냈지만, 상대적으로 산 생성이 적은 본 발명 B. cereus sp . 균주는 점도가 낮게 나타났다.
In general, fermented milk products such as yoghurt depend on the viscosity of consumers, so the viscosity of soymilk was 127 cps, but fermented soymilk was 325 at pH 5.5, 5.25, and 5.0, respectively. cps, 621 cps, 712 cps (Fig. 1B). Viscosity increased significantly between pH 5.5 and pH 5.25, resulting in slight curd formation and change in titratable acidity, and in sensory evaluation, sour taste increased. Rasic and Kurmann reported that the viscosity of yogurt was affected by the total solid content of the yogurt mixture, the degree of protein hydrolysis, the slime production capacity and the acid production capacity. Viscosity of milk fermented with lactic acid bacteria showed high viscosity (130 cps ~ 1930 cps) due to the production of large amounts of organic acids and aggregation of casein and whey protein, but relatively low acid production of the present invention B. cereus sp . The strain showed a low viscosity.
실험예Experimental Example 4. 4. 아미노태Amino 및 암모니아태 질소 함량 And ammonia nitrogen content
아미노태 질소 함량은 formol법으로 측정하였다. 시료 2 mL에 증류수 18 mL을 가하여 1시간 동안 상온에서 교반한 후, 중성 formalin (pH 8.4)용액 20 mL를 가한 다음, pH 8.4가 될 때까지 0.1 N NaOH로 적정하여 그 양으로 아미노태 질소의 함량을 측정하였다. 암모니아태 질소는 AM505-K (아산제약)에 의한 Indophenol법으로 측정하였다.
The amino nitrogen content was measured by the formol method. 18 mL of distilled water was added to 2 mL of the sample, stirred at room temperature for 1 hour, 20 mL of neutral formalin (pH 8.4) solution was added, titrated with 0.1 N NaOH until pH 8.4, and the amount of amino nitrogen The content was measured. Ammonia nitrogen was measured by Indophenol method by AM505-K (Asan Pharmaceuticals).
아미노태 질소 함량은 단백질이 아미노산의 형태로 분해되는 정도를 나타낸 것으로 protease의 작용에 의하므로 발효도를 평가할 때 사용되고 있다. [표 4] 에서 보듯이 아미노태 질소 함량은 두유는 542.5 mg/dL로 나타났으나, 발효가 시작됨에 따라 급격히 증가하여 pH 5.5에서 882 mg/dL였으며, 그 후 증가속도가 완만해져 pH 5.0까지 1190 mg/dL 의 아미노태 질소 함량을 나타내었다. 이로써 본 발명 B. cereus sp . 균주에 의한 두유의 발효는 단백질 가수분해 효소의 생성을 초래하며, 발효시간이 증가하면서 단백질 가수분해물이 증가하는 것을 알 수 있다. 암모니아태 질소는 단백질을 분해하는 과정에서 탈아미노화 반응에 의해 생성되며 암모니아성 질소가 과량 발생하게 되면 부패 혹은 변패의 지표로 사용된다. 두유의 암모니아태 질소함량은 129.1 μg/dL가 나타난 반면 발효가 진행되면서 pH 5.0 에서는 508.3 μg/dL까지 상승하였다. The amino nitrogen content indicates the degree of protein degradation in the form of amino acids. It is used to evaluate the fermentation degree due to the action of protease. As shown in [Table 4], the amino nitrogen content of soymilk was 542.5 mg / dL, but it increased rapidly as the fermentation began, ranging from pH 5.5 to 882 mg / dL, and then slowly increasing to pH 5.0. Amino nitrogen content of 1190 mg / dL was shown. Thus, the present invention B. cereus sp . Fermentation of soy milk by the strain results in the production of proteolytic enzymes, and it can be seen that the protein hydrolyzate increases as the fermentation time increases. Ammonia nitrogen is produced by deamination reactions in the process of protein decomposition, and is used as an indicator of decay or decay when excess ammonia nitrogen is generated. The soymilk's ammonia nitrogen content was 129.1 μg / dL, while as fermentation progressed, it increased to 508.3 μg / dL at pH 5.0.
실험예Experimental Example 5. 항산화 효과 측정 5. Antioxidant Effect Measurement
1,1-Diphenyl-2-picrylhydrazyl (DPPH) 소거효과 : 발효두유의 DPPH 소거효과능은 Blois의 방법에 준하여 추출물의 DPPH에 대한 수소공여 효과로 측정하였다. 농도별로 methanol에 녹인 시료 100 μL와 150 μM DPPH 용액 100 μL를 96-well plate에 혼합하여 30분간 실온에 방치시킨 후, 540 nm에서 분광광도계 (UV/VIS Spectrophotometer, Jasco, Japan)로 흡광도를 측정하였다. 시료를 첨가하지 않은 대조군과 비교하여 pH에 따른 발효두유의 흡광도 차이를 백분율(%)로 나타내었다.
1,1-Diphenyl-2-picrylhydrazyl (DPPH) scavenging effect: DPPH scavenging effect of fermented soybean milk was measured by the hydrogen donating effect of DPPH according to the method of Blois. 100 μL of the sample dissolved in methanol and 100 μL of the 150 μM DPPH solution were mixed in a 96-well plate and allowed to stand at room temperature for 30 minutes, and then the absorbance was measured at 540 nm using a UV / VIS Spectrophotometer (Jasco, Japan). It was. The difference in absorbance of fermented soymilk according to pH is expressed as a percentage (%) compared to the control without the sample.
수소 공여능을 측정하는 대표적인 방법인 DPPH는 비교적 안정한 free radical로써 짙은 자색을 나타내지만 항산화제, 방향족 아민류 등에 의해 전자가 쌍이 되어 환원되면 특유의 색이 사라지게 되는 것을 이용하여 항산화능을 측정하는 방법이다. DPPH, which is a representative method of measuring hydrogen donating ability, is a relatively stable free radical. It has a deep purple color.
DPPH radical 소거능법을 이용하여 발효에 따른 발효두유의 항산화효과 차이를 측정한 결과 발효두유는 농도 의존적으로 소거능을 나타냈다[도 2(A)]. 특히 2 mg/mL에서 두유는 50% 소거능을 나타낸 반면, 발효두유는 56%의 활성능을 보여 발효가 진행될수록 소거능이 증가하는 것으로 나타났다. As a result of measuring the antioxidant effect of fermented soybean milk by fermentation using DPPH radical scavenging method, fermented soymilk showed scavenging ability in a concentration-dependent manner [FIG. 2 (A)]. In particular, soymilk showed 50% scavenging activity at 2 mg / mL, while fermented soymilk showed 56% activating activity.
실험예Experimental Example 6. 6. HydroxyHydroxy radicalradical ( ( ㆍㆍ OHOH ) 소거활성Scavenging activity
Chung 등의 방법에 따라 10 mM FeSO4ㆍ7H2O-ethylenediaminetetraacetic acid disodium salt (EDTA)에 10 mM의 2-deoxyribose와 농도별 시료용액을 혼합한 다음, 10 mM의 H2O2 를 첨가하여 Fenton 반응에 따라 37℃에서 4시간 동안 배양한다. 이 혼합액에 2.8% trichloroacetic acid (TCA) 1.0 mL와 1.0% thiobarbituric acid (TBA) 1.0 mL 을 첨가하여 끓는 물에서 10분간 반응시킨 다음 냉각시킨 후 520 nm에서 UV-VIS spectrophotometer를 이용하여 흡광도를 측정하였다.
According to the method of Chung et al., 10 mM FeSO 4 ㆍ 7H 2 O-ethylenediaminetetraacetic acid disodium salt (EDTA) was mixed with 10 mM 2-deoxyribose and the sample solution by concentration, and then 10 mM H 2 O 2 was added to Fenton. Incubate at 37 ° C. for 4 hours according to the reaction. 1.0 mL of 2.8% trichloroacetic acid (TCA) and 1.0 mL of 1.0% thiobarbituric acid (TBA) were added to the mixture, reacted in boiling water for 10 minutes, cooled, and the absorbance was measured at 520 nm using a UV-VIS spectrophotometer. .
Hydroxy radical은 활성산소 중에서 화학적으로 반응성이 가장 크며 생체내의 산화 원인이 되며 DNA 손상을 주거나 돌연변이를 유발하는 물질로 알려져 있으므로 ㆍOH 소거활성에 의한 발효두유의 항산화 효과를 살펴보았다[도 2(B)]. 발효두유는 발효가 진행됨에 따라 ㆍOH 소거활성이 2 mg/mL농도에서는 23%에서 78%로 급격히 증가함을 알 수 있었다. 이는 Choi가 Bacillus로 발효한 여러 가지 두유에서 80% 이상의 ㆍOH 소거능을 보인 결과와 유사하다.
Hydroxy radicals are the most chemically reactive among the active oxygen and cause oxidation in vivo and are known to cause DNA damage or mutations. ㆍ The antioxidant effects of fermented soymilk by OH scavenging activity were examined [Fig. 2 (B) ]. As fermented soybean milk was fermented, OH scavenging activity increased rapidly from 23% to 78% at 2 mg / mL. This is similar to the result that Choi showed more than 80% ㆍ OH scavenging ability in various soymilk fermented with Bacillus .
실험예Experimental Example 7. 7. SuperoxideSuperoxide anionanion dismutasedismutase ( ( SODSOD ) ) 유사활성Pseudo-activity
Marklund와 Marklund의 방법에 따라 일정 농도의 시료 0.2 mL에 pH 8.5로 보정한 Tris-HCl buffer (50 mM Tris+10 mM EDTA, pH 8.5) 3 mL와 7.2 mM pyrogallol 0.2 mL를 첨가하여 25℃에서 10분간 반응시킨 후 1 N HCl (0.1 mL)로 반응을 정지시킨다. 반응액 중 산화된 pyrogallol의 양을 420 nm에서 흡광도를 측정하여 시료 첨가구와 무첨가구 사이의 흡광도 차이를 백분율(%)로 나타내었다.
According to Marklund and Marklund's method, add 3 mL of pH 8.5-corrected Tris-HCl buffer (50 mM Tris + 10 mM EDTA, pH 8.5) and 0.2 mL of 7.2 mM pyrogallol to 0.2 mL of sample at 10 ° C. After reacting for a minute, the reaction is stopped with 1 N HCl (0.1 mL). The absorbance of oxidized pyrogallol in the reaction solution was measured at 420 nm, and the difference in absorbance between the sample addition group and the no addition group was expressed as a percentage (%).
두유와 발효두유의 메탄올 추출물의 SOD 유사활성 효과를 pyrogallol에 대한 자동산화 반응을 이용하여 측정하였다. pH가 5.0인 발효두유에서는 2 mg/mL의 농도에서 50.6%의 활성을 보여 두유의 17.3% 보다 약 3배 높은 활성을 나타내었다(도3). SOD 유사활성능은 flavonoids 화합물과 페놀성 화합물을 많이 함유 할수록 높아지는 것으로 보고되고 있어, 발효두유의 SOD 유사활성효과는 발효가 진행 될수록 이 같은 화합물이 증가하여 나타난 것으로 사료된다.
SOD-like activity of methanol extracts of soymilk and fermented soymilk was measured by autooxidation reaction against pyrogallol. Fermented soymilk with a pH of 5.0 showed 50.6% of activity at a concentration of 2 mg / mL, which was about three times higher than that of 17.3% of soymilk (FIG. 3). The SOD-like activity was reported to increase with the addition of flavonoids and phenolic compounds. The SOD-like activity of fermented soybean milk increased as the compound increased with fermentation.
실험예Experimental Example 8. 8. InIn vitroin vitro 항암효과 Anticancer effect
암세포 배양 : AGS 인체 위암세포 (AGS human gasrtic adenocarcinoma cell)는 한국세포주은행 (서울의대)으로부터 분양받아 배양하면서 실험에 사용하였다. 암세포는 100 units/mL의 penicillin-streptomycin (GIBCO, USA)과 10%의 fetal bovine serum (FBS)이 함유된 RPMI 1640배지를 사용하여 37℃, 5% CO2 incubator (model 311, Forma, USA)에서 배양하였다. 배양된 각각의 암세포는 일주일에 2-3회 refeeding하고, 6-7일 만에 PBS로 세척한 후 0.05% trypsin-0.02% EDTA로 부착된 세포를 분리해 원심분리 하였다. 그 후 집적된 암세포에 배지를 넣고 피펫으로 암세포가 골고루 분산되도록 잘 혼합하여 cell culture flask에서 계대 배양하면서 실험에 사용하였다.
Cancer cell culture: AGS human gasrtic adenocarcinoma cells were used for the experiment while being cultured by the Korea Cell Line Bank (Seoul National University of Medicine). Cancer cells were cultured at 37 ° C and 5% CO 2 incubator (model 311, Forma, USA) using RPMI 1640 medium containing 100 units / mL penicillin-streptomycin (GIBCO, USA) and 10% fetal bovine serum (FBS). Incubated at. Each cultured cancer cells were refeeded 2-3 times a week, washed with PBS in 6-7 days, and then centrifuged by detaching cells attached with 0.05% trypsin-0.02% EDTA. Then, the culture medium was added to the integrated cancer cells, and the pipettes were mixed well so that the cancer cells were evenly distributed and used in the experiment while passaged in a cell culture flask.
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-zolium bromide (MTT) assay : 배양된 암세포는 96-well plate에 1×104 cells/well이 되게 180 μL씩 분주하고 시료를 적정 농도로 희석한 후 20 μL 첨가하여 37℃, 5% CO2 incubator에서 72시간 배양하였다. 여기에 Phosphate buffer saline (PBS)에 5 mg/mL의 농도로 제조한 MTT 용액 20 μL를 첨가하여 동 배양조건에서 4시간 더 배양하였다. 그 후 상등액을 제거하고 DMSO 150 μL를 각 well에 가하여 30분간 교반한 뒤 ELISA reader로 540 nm에서 흡광도를 측정하였다.
3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyltetra-zolium bromide (MTT) assay: Cultured cancer cells are divided into 180 μL in 1-104 cells / well in a 96-well plate and sampled. Was diluted to an appropriate concentration and 20 μL was added thereto, followed by incubation for 72 hours at 37 ° C. and 5% CO 2 incubator. To this was added 20 μL of a MTT solution prepared at a concentration of 5 mg / mL to Phosphate buffer saline (PBS) and further incubated for 4 hours under the same culture conditions. Then, the supernatant was removed, DMSO 150 μL was added to each well, stirred for 30 minutes, and the absorbance was measured at 540 nm with an ELISA reader.
본 발명 발효에 사용된 Bacillus Subtilis sp .(Bacillus 속 KC-1) 균주는 다른 B. subtilis와 비교하여 AGS 인체위암세포와 본 발명에서는 발효두유의 발효정도에 따른 암세포 성장억제 효과 차이를 AGS 인체 위암세포를 이용하여 확인한 결과(도 4), pH 5.5, pH 5.25, pH 5.0의 발효두유의 2 mg/mL의 농도에서 각각 76%, 93%, 95%의 저해율을 보여 두유는 발효가 진행될수록 인체 위암세포 성장 저해 효과를 가지는 것으로 보였다. 따라서, 본 발명 균주에 의하여 두유는 발효 시간이 경과함에 따라 암세포 성장 억제 증강 효과가 있는 것으로 판단되었다.
Bacillus used in the fermentation of the invention Subtilis sp . ( Bacillus The genus KC-1) strain is compared with other B. subtilis AGS human gastric cancer cells and the present invention confirmed the difference of cancer cell growth inhibition effect according to the fermentation degree of fermented soy milk using AGS human gastric cancer cells (Fig. 4), pH Inhibition rate of 76%, 93%, and 95% at 2 mg / mL of fermented soymilk at 5.5, pH 5.25, and pH 5.0, respectively, showed that the soymilk had the effect of inhibiting human gastric cancer cell growth as fermentation progressed. Therefore, according to the strain of the present invention, soymilk was determined to have an effect of enhancing cancer cell growth inhibition as the fermentation time elapsed.
통계분석Statistical analysis
대조군과 각 시료로부터 얻은 실험 결과들의 유의성을 검정하기 위하여 분산분석(ANOVA)을 행한 후 p<0.05 수준에서 Duncan's multiple range test를 실시하였으며, 그 결과는 평균(mean)±표준편차(standard deviation)로 표시하였다. 모든 통계분석은 Statistic Analysis System(v9.1 SAS Institute Inc., NC, USA) 통계프로그램을 이용하여 처리하였다.
In order to test the significance of the experimental results obtained from the control group and each sample, Duncan's multiple range test was performed at the p <0.05 level after ANOVA. The results were expressed as mean ± standard deviation. Indicated. All statistical analyzes were performed using the Statistic Analysis System (v9.1 SAS Institute Inc., NC, USA) statistical program.
본 발명 균주 B. Subtilis sp . 균주(KCCM 42923)는 두유발효 중 항산화 및 위암세포 성장억제능이 증대되는 뛰어난 효과가 있으므로 건강발효 식품산업상 매우 유용한 발명인 것이다.
Inventive strain B. Subtilis sp . Strain (KCCM 42923) is a very useful invention in the health fermented food industry because it has an excellent effect of increasing the antioxidant and gastric cancer cell growth inhibitory ability during soymilk fermentation.
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100040347 | 2010-04-29 | ||
KR20100040347 | 2010-04-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20110120802A true KR20110120802A (en) | 2011-11-04 |
KR101237795B1 KR101237795B1 (en) | 2013-02-28 |
Family
ID=45391900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100061766A KR101237795B1 (en) | 2010-04-29 | 2010-06-29 | A novel B. Subtilis sp. strain and fermented soymilk for anti-gastric cancer by using the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101237795B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190024420A (en) | 2017-08-31 | 2019-03-08 | 주영철 | Manufacturing method of soybean-yogurt improved taste and increased number of viable lactic acid bacteria |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190106039A (en) | 2018-03-07 | 2019-09-18 | 주식회사 리본인터내셔널 | Vegetable Protein Beverages and Method Thereof |
KR20220052559A (en) | 2020-10-21 | 2022-04-28 | 장영진 | Pharmaceutical composition for preventing or treating gastric cancer comprising anchovy processed product and/or soybean processed product as an active ingredient |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100242830B1 (en) | 1996-10-12 | 2000-02-01 | 전인장 | New strain bacillus sk-31, fermentative bean milk using the same and processes for the preparation thereof |
KR100578495B1 (en) | 2005-05-10 | 2006-05-10 | 조정일 | Process for preparing fermented soybean milk using chungkookjang |
-
2010
- 2010-06-29 KR KR1020100061766A patent/KR101237795B1/en not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190024420A (en) | 2017-08-31 | 2019-03-08 | 주영철 | Manufacturing method of soybean-yogurt improved taste and increased number of viable lactic acid bacteria |
Also Published As
Publication number | Publication date |
---|---|
KR101237795B1 (en) | 2013-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kumar Mishra et al. | Biofunctional attributes and storage study of soy milk fermented by Lactobacillus rhamnosus and Lactobacillus helveticus | |
KR101968242B1 (en) | Lactobacillus brevis ami-1109 and use thereof | |
KR102376622B1 (en) | Lactobacillus pentosus SRCM209254 strain having anti-inflammatory and antioxidant activity and uses thereof | |
KR101237795B1 (en) | A novel B. Subtilis sp. strain and fermented soymilk for anti-gastric cancer by using the same | |
Pradhananga | Effect of processing and soybean cultivar on natto quality using response surface methodology | |
Havas et al. | Performances of new isolates of Bifidobacterium on fermentation of soymilk | |
Kumar et al. | Screening for probiotic attributes of lactic acid bacteria isolated from human milk and evaluation of their anti-diabetic potentials | |
Park et al. | Producing functional soy-based yogurt incubated with bifidobacterium longum spm1205 isolated from healthy adult koreans | |
KR20210106930A (en) | Lactobacillus plantarum KCC-24 and composition comprising the same | |
KR100543242B1 (en) | Precess of enzyme health food having high activity by microbial fermentation | |
KR101381090B1 (en) | Method for producing fermented milk with high gaba and peptide content using serial fermentation of bacillus and lactococcus | |
KR102426030B1 (en) | Lactobacillus brevis SRCM209231 strain having enzyme activity, antimicrobial activity and probiotics property and uses thereof | |
KR100736255B1 (en) | Functional soybean paste fermented by Bacillus sp. and Lactobacillus casei and a method of preparing thereof | |
KR100362965B1 (en) | Preparation Method for Yogurt from Milk Added with Purple Sweet Potato | |
KR101673055B1 (en) | Novel starter strain and method functional fermentation foods containing bean curd use thereof | |
Hwang et al. | Changes in phytoestrogen contents and antioxidant activities during fermentation of soybean-powder milks prepared from different soybean cultivars by Lactobacillus plantarum P1201 | |
KR102242160B1 (en) | Novel Bacillus subtilis MKHJ 1-1 and uses thereof | |
KR102159380B1 (en) | Bacillus amyloliquefaciens SRCM101439 strain having antioxidant activity and probiotics property and uses thereof | |
KR100242830B1 (en) | New strain bacillus sk-31, fermentative bean milk using the same and processes for the preparation thereof | |
Sadishkumar et al. | The effect of Piper betle leaves on lacto-fermentation of idli batter, characterization and applicability of potent isolates in soymilk fermentation | |
KR19990008908A (en) | Method for producing soymilk fermented milk using enzyme-treated soymilk | |
KR101280538B1 (en) | A novel Lactic Acid producing Bacteria from Korean Traditional Meju and use thereof | |
KR20210076550A (en) | Methods for preparing oat doenjang using a novel Bacillus subtilis TSD | |
KR102457506B1 (en) | Lactobacillus pentosus SRCM216971 strain having antimicrobial activity against acne-causing strain and uses thereof | |
KR20130004456A (en) | Health functional food composition using pear young fruit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20160203 Year of fee payment: 4 |
|
LAPS | Lapse due to unpaid annual fee |